Concepedia

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

Myung‐Ju Ahn, Ji‐Youn Han, Ki Hyeong Lee, Sang-We Kim, Dong‐Wan Kim, Yun‐Gyoo Lee, Eun Kyung Cho, Joo-Hang Kim, Gyeong‐Won Lee, Jong Seok Lee,

The Lancet Oncology · 2019 · 135 citations · 8 references

DOI

Concepts

References

8

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata et al. · Science Translational Medicine · 2011 · 3.6K citations · Full text

, , +17

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

, , +16

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan et al. · Lung Cancer · 2015 · 526 citations · Full text

, , +14